Dr Melanie Walker
Qualifications: PhD
Bio: Dr Melanie Walker is a Senior Postdoctoral Fellow in the Viral Immunology Systems Program (VISP) and a Lecturer (Education Focused) in Pathology, School of Biomedical Sciences at UNSW Sydney. Her research focuses on understanding protective antibody responses to viral infections, with the aim of informing the development of vaccines.
Melanie completed her PhD in Pathology at UNSW, where she investigated viral evolution, transmitted founder virus characteristics, and humoral immune responses during early hepatitis C virus (HCV) infection. She then undertook a 5 year postdoctoral position at the University of Copenhagen, where she characterised human monoclonal antibody responses to Plasmodium falciparum malaria antigens and SARS-CoV-2.
Since returning to UNSW in 2023, Melanie has investigated immune responses to HCV, SARS-CoV-2 and other RNA viruses. Her research combines viral immunology, monoclonal antibody discovery, systems serology, bioinformatics and single-cell transcriptomics to understand protective immunity and inform vaccine development. She has contributed to NHMRC- (as CI-C) and MRFF- (as CI-D) funded research programs and has secured competitive CI-A funding through the Australian Centre for HIV and Hepatitis Virology Research and UNSW Triple I.
In addition to her research, Melanie is actively involved in undergraduate pathology education, where she convenes courses, develops innovative learning resources and authentic assessments, and contributes to curriculum
- Publications
- Media
- Grants
- Awards
- Research Activities
- Engagement
- Teaching and Supervision
MRFF (CI-D, $1,980,000.00, APP2035199). July 2024.
NHMRC Ideas grant (CI-C, $1,143,599.00, APP2020192). January 2023.
UNSW Triple I Seed grant (CI-A, $70,000). July 2024
Parse/Ramaciotti single cell grant (CI-A, $10,000). September 2025
Career Advancement Fund (CI-A, $10,000). August 2025
Australian Centre for HIV and Hepatitis Virology Research Seed funding (CI-A, $10,000). July 2024
School of Biomedical (SBMS) Systems Immunology Initiative (SII) seed funding scheme (CI-A, $12,000). July 2023